Collection of Samples USOPTIVAL Study
NCT04792684
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Colorectal Cancer (CRC)
- Advanced Adenomas (AA)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 45 to 84 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Universal Diagnostics
- Last updated on ClinicalTrials.gov
- November 10, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Lakeland Regional Cancer Center · Lakeland, FL
Illinois · 1
- Springfield Clinic · Springfield, IL
New York · 1
- Mid Hudson Medical Research · New Windsor, NY
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.